Integral Diagnostics H1 profits up on Capitol Health merger
Integral Diagnostics (ASX:IDX) saw revenue and other income climb to $393.5 million in H1 FY26, a 55.6% increase a year ago.
Todas as matérias desta categoria, das mais recentes às mais antigas.
Integral Diagnostics (ASX:IDX) saw revenue and other income climb to $393.5 million in H1 FY26, a 55.6% increase a year ago.
Pharmx Technologies (ASX:PHX) entered into a binding, multi-year strategic alliance with Sigma Healthcare (ASX:SIG).
Biome (ASX:BIO) has delivered its performance for the first half of FY26, headlined by a net profit of $1.2 million, a 172% increase over the previous year.
Aged care giant Regis Healthcare (ASX:REG) reported a sharp 45.1% decline in statutory net profit for the first half of FY26, falling to $13.4 million.
Mayne Pharma (ASX:MYX) reported revenue of $212.1 million for the first half of FY26, a marginal 0.5% decrease compared to the previous corresponding period.
Fisher & Paykel Healthcare (ASX:FPH) has upgraded its revenue and earnings guidance for the 2026 financial year ending March 31.
Telix Pharmaceuticals (ASX:TLX) reported a financial performance for the fiscal year ended Dec. 31, 2025, characterised by a 56% rise in total revenue to US$803.8 million.
Ramsay Health Care (ASX:RHC) announced a proposal to separate from its European subsidiary, Ramsay Santé.
Sonic Healthcare (ASX:SHL) announced its financial performance for the half-year ended Dec. 31, 2025, marked by double-digit revenue growth.
Medibank Group (ASX:MPL) reported a $297.8 million underlying net profit after tax for H1 FY26, a slight dip of 0.3%.
Telix Pharmaceuticals (ASX:TLX) submitted a Marketing Authorisation Application in Europe for its glioma imaging candidate, TLX101-Px.
Clinical-stage drug development company Nyrada (ASX:NYR) has released its half-year results for the 2026 fiscal year.
Tem um segundo para um cookie? 🍪Os cookies essenciais mantêm a Grafa funcionando bem. Alguns opcionais nos ajudam a ver o que está funcionando para melhorarmos. Você tem o controle — pode mudar de ideia quando quiser. Política de cookies · Política de privacidade